Acute Decompensated Heart Failure

Beta-blocker use at hospital admission for acute decompensated HF was associated with lower in-hospital mortality compared with nonuse before hospitalization, researchers reported.

Abiomed announced its right heart pump has received FDA premarket to treat acute right HF for up to 14 days.

In acute decompensated HF, moderate or severe mitral regurgitation occurred in nearly half of patients with ejection fraction below 50%, and its overall prevalence in this population varied by race/ethnicity and sex, researchers reported.

Ultrafiltration for acute decompensated HF reduced hospital readmission by 1.74 visits in the following 12 months compared with the prior year, according to data presented at the virtual Heart Failure Society of America Scientific Meeting.